CHANDIGARH: Bloodless hip surgery would be performed at the Gian Sagar Medical College and Hospital, near here, with an internationally acclaimed orthopaedic surgeon Gursharan Singh Chana visiting the hospital regularly every two months.

Disclosing this here Tuesday, Dr Sukhwinder Singh, vice-chairman of the Gian Sagar Educational and Charitable Trust, said that Dr Chana, who is settled in the United Kingdom, would visit the GSMCH every two months.

He would train orthopaedic surgeons in bloodless hip surgery for which a 15-day training course would be organized every two months.

Dr Sukhwinder Singh said that Gursharan Singh Chana, a doctor of Indian origin, would deliver a lecture on  minimal invasive surgery for total hip replacement and hip resurfacing at the Gian Sagar Medical College and Hospital on March 20.

He said that Dr Chana would interact with the faculty of the GSMCH on March 20 morning and in the evening he would address orthopaedic surgeons of Patiala. On March 21, he would be interacting with orthopaedic surgeons of Chandigarh and on march 22  he would have an interactive session with orthopaedicians of Ludhiana.

Dr Sukhwinder Singh said that an internationally acclaimed orthopaedic surgeon, Dr Chana has devised a minimally invasive approach to hip joint to carry out total hip replacement and hip resurfacing. He has devised Chana reamer handle to allow accurate surgery of the hip joint.

Dr Chana is presently working as a consultant orthopaedic surgeon at the Royal Orthopaedic Hospital, NHS Trust Birmingham, since October 2002.

Dr Chana has the vast experience of carrying out the over 2500 total hip replacements, over 2000 total knee replacement, over 1500 hip resurfacing, 200 hip replacements using minimally invasive surgical approach, 200 hip resurfacings using minimally invasive hip resurfacing. 

Over the last two years he has been involved in developing instrumentation and implants for hip resurfacing procedure to be carried out using a minimally invasive approach through Comis Orthopaedics, a company based in Yorkshire. 

The implant is being used currently in the U.K. This implant is the only one of its kind that can be delivered using a minimally invasive approach with obvious benefits of early discharge from hospital, blood transfusion is not necessary in 95 per cent of patients and the patients tend to return to normal activities at an earlier stage compared to patients who undergo open surgery. The average incision size is 7 cm. with this approach as opposed to 20 cm. using an open approach.